nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—Respiratory arrest—Vandetanib—thyroid cancer	0.0729	0.0729	CcSEcCtD
Procaine—Nephropathy—Vandetanib—thyroid cancer	0.0673	0.0673	CcSEcCtD
Procaine—Ventricular arrhythmia—Vandetanib—thyroid cancer	0.0433	0.0433	CcSEcCtD
Procaine—Cardiac arrest—Vandetanib—thyroid cancer	0.0221	0.0221	CcSEcCtD
Procaine—Neuropathy—Sorafenib—thyroid cancer	0.0203	0.0203	CcSEcCtD
Procaine—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.0166	0.0166	CcSEcCtD
Procaine—Bradycardia—Vandetanib—thyroid cancer	0.0164	0.0164	CcSEcCtD
Procaine—Vision blurred—Vandetanib—thyroid cancer	0.0132	0.0132	CcSEcCtD
Procaine—Tremor—Vandetanib—thyroid cancer	0.0131	0.0131	CcSEcCtD
Procaine—Eruption—Epirubicin—thyroid cancer	0.013	0.013	CcSEcCtD
Procaine—Loss of consciousness—Vandetanib—thyroid cancer	0.0123	0.0123	CcSEcCtD
Procaine—Convulsion—Vandetanib—thyroid cancer	0.0121	0.0121	CcSEcCtD
Procaine—Hypertension—Vandetanib—thyroid cancer	0.0121	0.0121	CcSEcCtD
Procaine—Eruption—Doxorubicin—thyroid cancer	0.012	0.012	CcSEcCtD
Procaine—Arthralgia—Vandetanib—thyroid cancer	0.0119	0.0119	CcSEcCtD
Procaine—Anxiety—Vandetanib—thyroid cancer	0.0119	0.0119	CcSEcCtD
Procaine—Neuropathy peripheral—Sorafenib—thyroid cancer	0.0119	0.0119	CcSEcCtD
Procaine—Paralysis—Epirubicin—thyroid cancer	0.0115	0.0115	CcSEcCtD
Procaine—Oedema—Vandetanib—thyroid cancer	0.0114	0.0114	CcSEcCtD
Procaine—Thrombocytopenia—Vandetanib—thyroid cancer	0.0112	0.0112	CcSEcCtD
Procaine—Ventricular arrhythmia—Epirubicin—thyroid cancer	0.0108	0.0108	CcSEcCtD
Procaine—Paralysis—Doxorubicin—thyroid cancer	0.0106	0.0106	CcSEcCtD
Procaine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.0104	0.0104	CcSEcCtD
Procaine—Tinnitus—Sorafenib—thyroid cancer	0.0101	0.0101	CcSEcCtD
Procaine—Ventricular arrhythmia—Doxorubicin—thyroid cancer	0.00999	0.00999	CcSEcCtD
Procaine—Fatigue—Vandetanib—thyroid cancer	0.00986	0.00986	CcSEcCtD
Procaine—Erythema—Sorafenib—thyroid cancer	0.00946	0.00946	CcSEcCtD
Procaine—Vasodilation—Epirubicin—thyroid cancer	0.0091	0.0091	CcSEcCtD
Procaine—Vasodilation procedure—Epirubicin—thyroid cancer	0.0091	0.0091	CcSEcCtD
Procaine—Body temperature increased—Vandetanib—thyroid cancer	0.00904	0.00904	CcSEcCtD
Procaine—Angioedema—Sorafenib—thyroid cancer	0.00864	0.00864	CcSEcCtD
Procaine—Syncope—Sorafenib—thyroid cancer	0.00848	0.00848	CcSEcCtD
Procaine—Leukopenia—Sorafenib—thyroid cancer	0.00846	0.00846	CcSEcCtD
Procaine—Vasodilation—Doxorubicin—thyroid cancer	0.00842	0.00842	CcSEcCtD
Procaine—Vasodilation procedure—Doxorubicin—thyroid cancer	0.00842	0.00842	CcSEcCtD
Procaine—Loss of consciousness—Sorafenib—thyroid cancer	0.00831	0.00831	CcSEcCtD
Procaine—Atrioventricular block—Epirubicin—thyroid cancer	0.00824	0.00824	CcSEcCtD
Procaine—Hypertension—Sorafenib—thyroid cancer	0.00816	0.00816	CcSEcCtD
Procaine—Pruritus—Vandetanib—thyroid cancer	0.00809	0.00809	CcSEcCtD
Procaine—Arthralgia—Sorafenib—thyroid cancer	0.00805	0.00805	CcSEcCtD
Procaine—Diarrhoea—Vandetanib—thyroid cancer	0.00783	0.00783	CcSEcCtD
Procaine—Anaphylactic shock—Sorafenib—thyroid cancer	0.00772	0.00772	CcSEcCtD
Procaine—Atrioventricular block—Doxorubicin—thyroid cancer	0.00763	0.00763	CcSEcCtD
Procaine—Shock—Sorafenib—thyroid cancer	0.00759	0.00759	CcSEcCtD
Procaine—Dizziness—Vandetanib—thyroid cancer	0.00756	0.00756	CcSEcCtD
Procaine—Thrombocytopenia—Sorafenib—thyroid cancer	0.00756	0.00756	CcSEcCtD
Procaine—Neuropathy—Epirubicin—thyroid cancer	0.0075	0.0075	CcSEcCtD
Procaine—Vomiting—Vandetanib—thyroid cancer	0.00727	0.00727	CcSEcCtD
Procaine—Rash—Vandetanib—thyroid cancer	0.00721	0.00721	CcSEcCtD
Procaine—Dermatitis—Vandetanib—thyroid cancer	0.00721	0.00721	CcSEcCtD
Procaine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00703	0.00703	CcSEcCtD
Procaine—Neuropathy—Doxorubicin—thyroid cancer	0.00694	0.00694	CcSEcCtD
Procaine—Nausea—Vandetanib—thyroid cancer	0.00679	0.00679	CcSEcCtD
Procaine—Fatigue—Sorafenib—thyroid cancer	0.00665	0.00665	CcSEcCtD
Procaine—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00615	0.00615	CcSEcCtD
Procaine—Urticaria—Sorafenib—thyroid cancer	0.00613	0.00613	CcSEcCtD
Procaine—Body temperature increased—Sorafenib—thyroid cancer	0.0061	0.0061	CcSEcCtD
Procaine—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.006	0.006	CcSEcCtD
Procaine—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00569	0.00569	CcSEcCtD
Procaine—Hypersensitivity—Sorafenib—thyroid cancer	0.00569	0.00569	CcSEcCtD
Procaine—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00555	0.00555	CcSEcCtD
Procaine—Cardiac arrest—Epirubicin—thyroid cancer	0.00552	0.00552	CcSEcCtD
Procaine—Pruritus—Sorafenib—thyroid cancer	0.00546	0.00546	CcSEcCtD
Procaine—Diarrhoea—Sorafenib—thyroid cancer	0.00528	0.00528	CcSEcCtD
Procaine—Cardiac arrest—Doxorubicin—thyroid cancer	0.00511	0.00511	CcSEcCtD
Procaine—Dizziness—Sorafenib—thyroid cancer	0.0051	0.0051	CcSEcCtD
Procaine—Eosinophilia—Epirubicin—thyroid cancer	0.00497	0.00497	CcSEcCtD
Procaine—Vomiting—Sorafenib—thyroid cancer	0.00491	0.00491	CcSEcCtD
Procaine—Rash—Sorafenib—thyroid cancer	0.00487	0.00487	CcSEcCtD
Procaine—Dermatitis—Sorafenib—thyroid cancer	0.00486	0.00486	CcSEcCtD
Procaine—Eosinophilia—Doxorubicin—thyroid cancer	0.00459	0.00459	CcSEcCtD
Procaine—Nausea—Sorafenib—thyroid cancer	0.00458	0.00458	CcSEcCtD
Procaine—Drowsiness—Epirubicin—thyroid cancer	0.00447	0.00447	CcSEcCtD
Procaine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00438	0.00438	CcSEcCtD
Procaine—Drowsiness—Doxorubicin—thyroid cancer	0.00414	0.00414	CcSEcCtD
Procaine—Bradycardia—Epirubicin—thyroid cancer	0.00409	0.00409	CcSEcCtD
Procaine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00406	0.00406	CcSEcCtD
Procaine—Bradycardia—Doxorubicin—thyroid cancer	0.00378	0.00378	CcSEcCtD
Procaine—Tinnitus—Epirubicin—thyroid cancer	0.00374	0.00374	CcSEcCtD
Procaine—Chills—Epirubicin—thyroid cancer	0.0036	0.0036	CcSEcCtD
Procaine—Erythema—Epirubicin—thyroid cancer	0.00349	0.00349	CcSEcCtD
Procaine—Tinnitus—Doxorubicin—thyroid cancer	0.00346	0.00346	CcSEcCtD
Procaine—Tension—Epirubicin—thyroid cancer	0.00343	0.00343	CcSEcCtD
Procaine—Nervousness—Epirubicin—thyroid cancer	0.00339	0.00339	CcSEcCtD
Procaine—Chills—Doxorubicin—thyroid cancer	0.00333	0.00333	CcSEcCtD
Procaine—Vision blurred—Epirubicin—thyroid cancer	0.00329	0.00329	CcSEcCtD
Procaine—Erythema—Doxorubicin—thyroid cancer	0.00323	0.00323	CcSEcCtD
Procaine—Agitation—Epirubicin—thyroid cancer	0.00321	0.00321	CcSEcCtD
Procaine—Tension—Doxorubicin—thyroid cancer	0.00317	0.00317	CcSEcCtD
Procaine—Nervousness—Doxorubicin—thyroid cancer	0.00314	0.00314	CcSEcCtD
Procaine—Syncope—Epirubicin—thyroid cancer	0.00313	0.00313	CcSEcCtD
Procaine—Leukopenia—Epirubicin—thyroid cancer	0.00313	0.00313	CcSEcCtD
Procaine—Loss of consciousness—Epirubicin—thyroid cancer	0.00307	0.00307	CcSEcCtD
Procaine—Vision blurred—Doxorubicin—thyroid cancer	0.00305	0.00305	CcSEcCtD
Procaine—Convulsion—Epirubicin—thyroid cancer	0.00303	0.00303	CcSEcCtD
Procaine—Hypertension—Epirubicin—thyroid cancer	0.00302	0.00302	CcSEcCtD
Procaine—Arthralgia—Epirubicin—thyroid cancer	0.00297	0.00297	CcSEcCtD
Procaine—Agitation—Doxorubicin—thyroid cancer	0.00297	0.00297	CcSEcCtD
Procaine—Anxiety—Epirubicin—thyroid cancer	0.00296	0.00296	CcSEcCtD
Procaine—Syncope—Doxorubicin—thyroid cancer	0.0029	0.0029	CcSEcCtD
Procaine—Leukopenia—Doxorubicin—thyroid cancer	0.00289	0.00289	CcSEcCtD
Procaine—Anaphylactic shock—Epirubicin—thyroid cancer	0.00285	0.00285	CcSEcCtD
Procaine—Oedema—Epirubicin—thyroid cancer	0.00285	0.00285	CcSEcCtD
Procaine—Loss of consciousness—Doxorubicin—thyroid cancer	0.00284	0.00284	CcSEcCtD
Procaine—Shock—Epirubicin—thyroid cancer	0.00281	0.00281	CcSEcCtD
Procaine—Convulsion—Doxorubicin—thyroid cancer	0.0028	0.0028	CcSEcCtD
Procaine—Thrombocytopenia—Epirubicin—thyroid cancer	0.00279	0.00279	CcSEcCtD
Procaine—Hypertension—Doxorubicin—thyroid cancer	0.00279	0.00279	CcSEcCtD
Procaine—Tachycardia—Epirubicin—thyroid cancer	0.00278	0.00278	CcSEcCtD
Procaine—Hyperhidrosis—Epirubicin—thyroid cancer	0.00276	0.00276	CcSEcCtD
Procaine—Arthralgia—Doxorubicin—thyroid cancer	0.00275	0.00275	CcSEcCtD
Procaine—Anxiety—Doxorubicin—thyroid cancer	0.00274	0.00274	CcSEcCtD
Procaine—Hypotension—Epirubicin—thyroid cancer	0.00266	0.00266	CcSEcCtD
Procaine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00264	0.00264	CcSEcCtD
Procaine—Oedema—Doxorubicin—thyroid cancer	0.00264	0.00264	CcSEcCtD
Procaine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Procaine—Shock—Doxorubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Procaine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00258	0.00258	CcSEcCtD
Procaine—Tachycardia—Doxorubicin—thyroid cancer	0.00258	0.00258	CcSEcCtD
Procaine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00255	0.00255	CcSEcCtD
Procaine—Somnolence—Epirubicin—thyroid cancer	0.00254	0.00254	CcSEcCtD
Procaine—Hypotension—Doxorubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Procaine—Fatigue—Epirubicin—thyroid cancer	0.00246	0.00246	CcSEcCtD
Procaine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.0024	0.0024	CcSEcCtD
Procaine—Somnolence—Doxorubicin—thyroid cancer	0.00235	0.00235	CcSEcCtD
Procaine—Fatigue—Doxorubicin—thyroid cancer	0.00228	0.00228	CcSEcCtD
Procaine—Urticaria—Epirubicin—thyroid cancer	0.00227	0.00227	CcSEcCtD
Procaine—Body temperature increased—Epirubicin—thyroid cancer	0.00225	0.00225	CcSEcCtD
Procaine—Hypersensitivity—Epirubicin—thyroid cancer	0.0021	0.0021	CcSEcCtD
Procaine—Urticaria—Doxorubicin—thyroid cancer	0.0021	0.0021	CcSEcCtD
Procaine—Body temperature increased—Doxorubicin—thyroid cancer	0.00209	0.00209	CcSEcCtD
Procaine—Pruritus—Epirubicin—thyroid cancer	0.00202	0.00202	CcSEcCtD
Procaine—Diarrhoea—Epirubicin—thyroid cancer	0.00195	0.00195	CcSEcCtD
Procaine—Hypersensitivity—Doxorubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
Procaine—Dizziness—Epirubicin—thyroid cancer	0.00189	0.00189	CcSEcCtD
Procaine—Pruritus—Doxorubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Procaine—Vomiting—Epirubicin—thyroid cancer	0.00181	0.00181	CcSEcCtD
Procaine—Diarrhoea—Doxorubicin—thyroid cancer	0.00181	0.00181	CcSEcCtD
Procaine—Rash—Epirubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Procaine—Dermatitis—Epirubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Procaine—Dizziness—Doxorubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Procaine—Nausea—Epirubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Procaine—Vomiting—Doxorubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Procaine—Rash—Doxorubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Procaine—Dermatitis—Doxorubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Procaine—Nausea—Doxorubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
